EUVIMEDEUVIMED entdecken
Open Access

Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia

Yoon Soo Chang, Joell J Gills, Shigeru Kawabata, Masahiro Onozawa, Giusy Della Gatta, Adolfo A Ferrando, Peter D Aplan, Phillip A Dennis

International Journal of Oncology · 2023

DOI: 10.3892/ijo.2023.5576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Yoon Soo Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Nelfinavir, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NelfinavirPrecursor T-Cell Lymphoblastic Leukemia-LymphomaHumansMiceAnimalsPresenilin-1Proto-Oncogene Proteins c-aktAmyloid Precursor Protein SecretasesTOR Serine-Threonine KinasesEnzyme InhibitorsTranscription FactorsMice, TransgenicRNA, MessengerReceptor, Notch1Cell Line, TumorSestrins

Stichwörter der Autor:innen

NOTCH pathwayT cell acute lymphoblastic leukemiamTOR pathwaynelfinavir

Substanzen

NelfinavirPresenilin-1Proto-Oncogene Proteins c-aktAmyloid Precursor Protein SecretasesTOR Serine-Threonine KinasesEnzyme InhibitorsTranscription FactorsRNA, MessengerReceptor, Notch1SESN2 protein, human

Autor:innen und Institutionen

  • Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Institute for Cancer Genetics and Joint Centers for Systems Biology, Columbia University, New York, NY 10032, USA.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Chang, Y. S., Gills, J. J., Kawabata, S., Onozawa, M., Della Gatta, G., Ferrando, A. A., Aplan, P. D., & Dennis, P. A. (2023). Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5576

Vancouver

Chang YS, Gills JJ, Kawabata S, Onozawa M, Della Gatta G, Ferrando AA, et al. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5576

BibTeX
@article{Chang2023,
  author = {Chang, Yoon Soo and Gills, Joell J and Kawabata, Shigeru and Onozawa, Masahiro and Della Gatta, Giusy and Ferrando, Adolfo A and Aplan, Peter D and Dennis, Phillip A},
  title = {Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia},
  journal = {International Journal of Oncology},
  year = {2023},
  doi = {10.3892/ijo.2023.5576}
}
Kostenlos starten →